Emcure Pharmaceuticals
 | |
| Type | MNC (JVs and subsidiaries) |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1983 |
| Headquarters | Hinjwadi, Pune, India |
| Key people | Satish Mehta CEO |
| Products | Tablets, Capsules, Soft gels, Injectables, Lyophilized sterile parenterals, Onco products |
| Employees | approximately 6000 |
| Website | www.emcure.co.in |
Emcure Pharmaceuticals headquartered at Pune in West India is a vertically integrated Indian pharmaceutical company. The company's products include Tablets, Capsules ( both Softgel capsules and hard-gel capsules), and injectables. Emcure has proven capabilities to research, develop and supply finished formulations to the most demanding needs of the global regulated markets.
Indian plants
US plant
USA - The company has a manufacturing facility and R&D centre at East Brunswick, New Jersey, USA.
Capital markets
Emcure is planning to raise money through an initial public offering
Key products
AIDS Initiative
Emcure voices its concerns on HIV/AIDS through its "Let's fight AIDS together" initiative and supplies Antiretroviral drugs to Africa, Asia Pacific and CIS. As a part of its corporate social responsibility it supports 'Taal', a pharmacy for HIV/AIDS patients run by HIV/AIDS patients.
Emcure has license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs.
Group Companies
External links
References
Retrieved from : http://en.wikipedia.org/wiki/Emcure_Pharmaceuticals
No comments:
Post a Comment